U.S. Dna Synthesis Market Size & Outlook, 2023-2030
U.S. dna synthesis market, 2018-2030 (US$M)
Related Markets
U.S. dna synthesis market highlights
- The U.S. dna synthesis market generated a revenue of USD 1,146.9 million in 2023 and is expected to reach USD 2,966.5 million by 2030.
- The U.S. market is expected to grow at a CAGR of 14.5% from 2024 to 2030.
- In terms of segment, oligonucleotide synthesis was the largest revenue generating service type in 2023.
- Gene Synthesis is the most lucrative service type segment registering the fastest growth during the forecast period.
Dna synthesis market data book summary
| Market revenue in 2023 | USD 1,146.9 million |
| Market revenue in 2030 | USD 2,966.5 million |
| Growth rate | 14.5% (CAGR from 2023 to 2030) |
| Largest segment | Oligonucleotide synthesis |
| Fastest growing segment | Gene Synthesis |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Oligonucleotide Synthesis, Gene Synthesis |
| Key market players worldwide | Thermo Fisher Scientific Inc, Twist Bioscience Corp, Codexis Inc, LGC Group, Eurofins Scientific SE, Genscript Biotech Corp Class H, Bioneer, IBA Lifesciences, Danaher Corp, Quintarabio |
Other key industry trends
- In terms of revenue, U.S. accounted for 36.6% of the global dna synthesis market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. dna synthesis market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 286.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
DNA Synthesis Market Scope
DNA Synthesis Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. dna synthesis market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dna synthesis market will help companies and investors design strategic landscapes.
Oligonucleotide synthesis was the largest segment with a revenue share of 56% in 2023. Horizon Databook has segmented the U.S. dna synthesis market based on oligonucleotide synthesis, gene synthesis covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. DNA synthesis market has witnessed significant growth in recent years. Growth in the region can be attributed to the increasing demand for synthetic DNA & RNA sequences in various applications, such as research, diagnostics, and therapeutics.
The competitive landscape of this market is characterized by a mix of established players and emerging companies striving to capture a share of the expanding market. Integrated DNA Technologies, Thermo Fisher Scientific, and Eurofins Scientific are some of the leading players in the DNA synthesis market, known for their comprehensive portfolio of high-quality products & services.
The growing funding to advance enzymatic DNA synthesis technologies is anticipated to boost the market in the region. For instance, in April 2021, the U.S. government invested around USD 1.7 billion in Association of American Medical Colleges genome sequencing to better detect, monitor, and mitigate COVID variants.
Reasons to subscribe to U.S. dna synthesis market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. dna synthesis market databook
-
Our clientele includes a mix of dna synthesis market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. dna synthesis market, including forecasts for subscribers. This country databook contains high-level insights into U.S. dna synthesis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. dna synthesis market report size, by service type, 2018-2030 (US$M)
U.S. DNA Synthesis Market Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
